The PE Ratio as of November 2024 (TTM) for Evogene Ltd. (EVGN) is -0.42

According to Evogene Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.42. This represents a change of -77.72% compared to the average of -1.89 of the last 4 quarters.

Evogene Ltd. (EVGN) Historical PE Ratio (quarterly & annually)

How has EVGN PE Ratio performed in the past?

The mean historical PE Ratio of Evogene Ltd. over the last ten years is -43.83. The current -0.42 PE Ratio has changed -4.17% with respect to the historical average. Over the past ten years (40 quarters), EVGN's PE Ratio was at its highest in in the June 2023 quarter at -0.16. The PE Ratio was at its lowest in in the September 2014 quarter at -193.53.

Evogene Ltd. (EVGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Evogene Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evogene Ltd. (EVGN) Average PE Ratio

How has EVGN PE Ratio performed in the past?

The current PE Ratio of Evogene Ltd. (EVGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Evogene Ltd. (EVGN) PE Ratio vs. Peers

How is EVGN’s PE Ratio compared to its peers?

Evogene Ltd.’s PE Ratio is greater than Arcus Biosciences, Inc. (-4.98), greater than Fate Therapeutics, Inc. (-1.51), greater than Surface Oncology, Inc. (-0.91), greater than Pluri Inc. (-1.17), greater than Lexaria Bioscience Corp. (-5.97), less than Navidea Biopharmaceuticals, Inc. (0.03), less than ZyVersa Therapeutics, Inc. (-0.00), less than Biodexa Pharmaceuticals Plc (-0.18), less than Oncorus, Inc. (-0.04), greater than Can-Fite BioPharma Ltd. (-484.44), less than ImmuCell Corporation (-0.04), less than Compugen Ltd. (78.95), greater than CollPlant Biotechnologies Ltd. (-2.71), less than Protalix BioTherapeutics, Inc. (0), greater than Corvus Pharmaceuticals, Inc. (-12.94), greater than Aldeyra Therapeutics, Inc. (-10.50), greater than Gamida Cell Ltd. (-6.45), less than Checkpoint Therapeutics, Inc. (-0.23), greater than null (-3.48),

Build a custom stock screener for Evogene Ltd. (EVGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evogene Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evogene Ltd. (EVGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evogene Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.